Tau passive immunotherapy in mutant P301L mice: antibody affinity versus specificity.

d'Abramo, Cristina; Acker, Christopher M; Jimenez, Heidy T; Davies, Peter

d'Abramo, Cristina; Acker, Christopher M; Jimenez, Heidy T; Davies, Peter.

Affiliation

d'Abramo C; Litwin-Zucker Center for Research in Alzheimer's Disease, Feinstein Institute for Medical Research, North Shore LIJ Health System, Manhasset, New York, United States of America.

PLoS One ; 8(4): e62402, 2013.

Article in En | MEDLINE | ID: mdl-23638068

Subject(s)

Antibody Affinity; Antibody Specificity; Immunization, Passive/methods; Mutation; tau Proteins/immunology; Animals; Antibodies, Monoclonal/immunology; Antibodies, Monoclonal/therapeutic use; CA1 Region, Hippocampal/metabolism; Female; Mice; Phosphorylation/immunology; Prosencephalon/metabolism; Tauopathies/immunology; Tauopathies/therapy; Time Factors; tau Proteins/genetics

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunization, Passive / Tau Proteins / Antibody Affinity / Antibody Specificity / Mutation Type of study: Prognostic_studies Limits: Animals Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2013 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google